Qiagen said this week that the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai School of Medicine has selected its Ingenuity Variant Analysis software solution for translational research applications around characterizing and identifying rare diseases.
In addition, the software will also be used for training purposes. Research scientists and medical students at the institute will also use Variant Analysis to analyze data from their own genomes.
Qiagen also announced that the Center for Applied Genomics at the Children's Hospital of Philadelphia has integrated Variant Analysis into a bioinformatics pipeline that it is using for a next-generation sequencing-based study that aims to identify causative variants in rare pediatric diseases.
The financial details of both agreements were not disclosed.